[1]
S. SAYIN, “COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR: Infection With PTCy Versus Standard GvHD Prophylaxis”, Mediterr J Hematol Infect Dis, vol. 16, no. 1, p. e2024016, Feb. 2024.